Literature DB >> 26203138

Gene-Silencing Screen for Mammalian Axon Regeneration Identifies Inpp5f (Sac2) as an Endogenous Suppressor of Repair after Spinal Cord Injury.

Yixiao Zou1, Massimiliano Stagi1, Xingxing Wang1, Kazim Yigitkanli1, Chad S Siegel1, Fubito Nakatsu1, William B J Cafferty1, Stephen M Strittmatter2.   

Abstract

Axonal growth and neuronal rewiring facilitate functional recovery after spinal cord injury. Known interventions that promote neural repair remain limited in their functional efficacy. To understand genetic determinants of mammalian CNS axon regeneration, we completed an unbiased RNAi gene-silencing screen across most phosphatases in the genome. We identified one known and 17 previously unknown phosphatase suppressors of injury-induced CNS axon growth. Silencing Inpp5f (Sac2) leads to robust enhancement of axon regeneration and growth cone reformation. Results from cultured Inpp5f(-/-) neurons confirm lentiviral shRNA results from the screen. Consistent with the nonoverlapping substrate specificity between Inpp5f and PTEN, rapamycin does not block enhanced regeneration in Inpp5f(-/-) neurons, implicating mechanisms independent of the PI3K/AKT/mTOR pathway. Inpp5f(-/-) mice develop normally, but show enhanced anatomical and functional recovery after mid-thoracic dorsal hemisection injury. More serotonergic axons sprout and/or regenerate caudal to the lesion level, and greater numbers of corticospinal tract axons sprout rostral to the lesion. Functionally, Inpp5f-null mice exhibit enhanced recovery of motor functions in both open-field and rotarod tests. This study demonstrates the potential of an unbiased high-throughput functional screen to identify endogenous suppressors of CNS axon growth after injury, and reveals Inpp5f (Sac2) as a novel suppressor of CNS axon repair after spinal cord injury. Significance statement: The extent of axon regeneration is a critical determinant of neurological recovery from injury, and is extremely limited in the adult mammalian CNS. We describe an unbiased gene-silencing screen that uncovered novel molecules suppressing axonal regeneration. Inpp5f (Sac2) gene deletion promoted recovery from spinal cord injury with no side effects. The mechanism of action is distinct from another lipid phosphatase implicated in regeneration, PTEN. This opens new pathways for investigation in spinal cord injury research. Furthermore the screening methodology can be applied on a genome wide scale to discovery the entire set of mammalian genes contributing to axonal regeneration.
Copyright © 2015 the authors 0270-6474/15/3510429-11$15.00/0.

Entities:  

Keywords:  axon regeneration; inositol phosphate; sac2; siRNA; spinal cord injury

Mesh:

Substances:

Year:  2015        PMID: 26203138      PMCID: PMC4510284          DOI: 10.1523/JNEUROSCI.1718-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration.

Authors:  Ali Ertürk; Farida Hellal; Joana Enes; Frank Bradke
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

2.  Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness.

Authors:  Wenting Zhu; Chinmay M Trivedi; Diane Zhou; Lijun Yuan; Min Min Lu; Jonathan A Epstein
Journal:  Circ Res       Date:  2009-10-29       Impact factor: 17.367

3.  Growing dendrites and axons differ in their reliance on the secretory pathway.

Authors:  Bing Ye; Ye Zhang; Wei Song; Susan H Younger; Lily Yeh Jan; Yuh Nung Jan
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

4.  SOCS3 deletion promotes optic nerve regeneration in vivo.

Authors:  Patrice D Smith; Fang Sun; Kevin Kyungsuk Park; Bin Cai; Chen Wang; Kenichiro Kuwako; Irene Martinez-Carrasco; Lauren Connolly; Zhigang He
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

5.  PirB is a functional receptor for myelin inhibitors of axonal regeneration.

Authors:  Jasvinder K Atwal; Julie Pinkston-Gosse; Josh Syken; Scott Stawicki; Yan Wu; Carla Shatz; Marc Tessier-Lavigne
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

6.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

7.  Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice.

Authors:  Elizabeth J Fry; Melanie J Chagnon; Rubèn López-Vales; Michel L Tremblay; Samuel David
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

8.  Negative guidance factor-induced macropinocytosis in the growth cone plays a critical role in repulsive axon turning.

Authors:  Adrianne L Kolpak; Jun Jiang; Daorong Guo; Clive Standley; Karl Bellve; Kevin Fogarty; Zheng-Zheng Bao
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

9.  KLF family members regulate intrinsic axon regeneration ability.

Authors:  Darcie L Moore; Murray G Blackmore; Ying Hu; Klaus H Kaestner; John L Bixby; Vance P Lemmon; Jeffrey L Goldberg
Journal:  Science       Date:  2009-10-09       Impact factor: 47.728

10.  Axon regeneration requires a conserved MAP kinase pathway.

Authors:  Marc Hammarlund; Paola Nix; Linda Hauth; Erik M Jorgensen; Michael Bastiani
Journal:  Science       Date:  2009-01-22       Impact factor: 47.728

View more
  22 in total

Review 1.  Reconnecting Eye to Brain.

Authors:  Michael C Crair; Carol A Mason
Journal:  J Neurosci       Date:  2016-10-19       Impact factor: 6.167

Review 2.  Activity-Dependent Gene Expression in the Mammalian Olfactory Epithelium.

Authors:  Qiang Wang; William B Titlow; Declan A McClintock; Arnold J Stromberg; Timothy S McClintock
Journal:  Chem Senses       Date:  2017-10-01       Impact factor: 3.160

3.  Epigenetic profiling reveals a developmental decrease in promoter accessibility during cortical maturation in vivo.

Authors:  Ishwariya Venkatesh; Matthew T Simpson; Denise M Coley; Murray G Blackmore
Journal:  Neuroepigenetics       Date:  2016-11-23

4.  The application of CRISPR technology to high content screening in primary neurons.

Authors:  Ben L Callif; Brian Maunze; Nick L Krueger; Matthew T Simpson; Murray G Blackmore
Journal:  Mol Cell Neurosci       Date:  2017-01-19       Impact factor: 4.314

5.  Inositol Polyphosphate-5-Phosphatase K (Inpp5k) Enhances Sprouting of Corticospinal Tract Axons after CNS Trauma.

Authors:  Sierra D Kauer; Kathryn L Fink; Elizabeth H F Li; Brian P Evans; Noa Golan; William B J Cafferty
Journal:  J Neurosci       Date:  2022-02-08       Impact factor: 6.709

Review 6.  Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.

Authors:  Daniel J Cooper; Giulia Zunino; John L Bixby; Vance P Lemmon
Journal:  Mol Cell Neurosci       Date:  2016-07-18       Impact factor: 4.314

7.  The nociceptin receptor inhibits axonal regeneration and recovery from spinal cord injury.

Authors:  Yuichi Sekine; Chad S Siegel; Tomoko Sekine-Konno; William B J Cafferty; Stephen M Strittmatter
Journal:  Sci Signal       Date:  2018-04-03       Impact factor: 8.192

8.  Optogenetic Interrogation of Functional Synapse Formation by Corticospinal Tract Axons in the Injured Spinal Cord.

Authors:  Naveen Jayaprakash; Zimei Wang; Brian Hoeynck; Nicholas Krueger; Audra Kramer; Eric Balle; Daniel S Wheeler; Robert A Wheeler; Murray G Blackmore
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

Review 9.  In vitro models of axon regeneration.

Authors:  Hassan Al-Ali; Samuel R Beckerman; John L Bixby; Vance P Lemmon
Journal:  Exp Neurol       Date:  2016-01-27       Impact factor: 5.330

10.  Functional Genome-wide Screen Identifies Pathways Restricting Central Nervous System Axonal Regeneration.

Authors:  Yuichi Sekine; Alexander Lin-Moore; Devon M Chenette; Xingxing Wang; Zhaoxin Jiang; William B Cafferty; Marc Hammarlund; Stephen M Strittmatter
Journal:  Cell Rep       Date:  2018-04-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.